Results 71 to 80 of about 1,565 (185)

Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 3, Page 1740-1745, September 1, 2025.
ABSTRACT Vasoplegic syndrome (VS) is a common complication after cardiac surgery with cardiopulmonary bypass (CPB). The main pathophysiology mechanism of VS includes a systemic inflammatory response syndrome due to surgical trauma, release of pro‐inflammatory mediators caused by blood contact with foreign surfaces of heart‐lung machine (pump and tubing)
Matteo Lucchelli   +3 more
wiley   +1 more source

Treatment of Restless Legs Syndrome in Dialysis Patients

open access: yes
Seminars in Dialysis, Volume 39, Issue 4, Page 207-209, July/August 2026.
Kenji Sakurai   +4 more
wiley   +1 more source

Red Blood Cell‐Induced Bacterial Margination Improves Microbial Hemoadsorption on Engineered Cell‐Depleted Thrombi, Restoring Severe Bacteremia in Rats

open access: yesAdvanced Science, Volume 12, Issue 29, August 7, 2025.
A highly efficient extracorporeal device for treating bacteremia is developed by integrating microfluidic bacterial margination and engineered cell‐depleted thrombi strategically constructed in the device. The rodent models, severely infected with antibiotic‐resistant bacteria, recover from bacteremia after two subsequent extracorporeal blood ...
Bong Hwan Jang   +4 more
wiley   +1 more source

Granulocyte and Monocyte Adsorption Therapy in Patients With Sepsis: A Feasibility Study

open access: yesArtificial Organs, Volume 49, Issue 5, Page 852-863, May 2025.
The median SOFA score decreased from 10 to 4 after 7 days. Decreased circulatory and renal SOFA scores were characteristic. Granulocytes, mainly neutrophils, were adsorbed, and the neutrophil‐to‐lymphocyte ratio significantly improved. The median APACHE II score was 27, and the 28‐day mortality rate was 7.8%.
Osamu Nishida   +20 more
wiley   +1 more source

A rare case of hepatitis a virus-induced acute liver failure managed by hemoadsorption CytoSorb and Biosky MG 350 [PDF]

open access: yes
Acute liver failure (ALF) is a severe and life-threatening condition characterized by rapid hepatic dysfunction, leading to multi-organ failure and a high mortality rate.
Mondal, Mithun Kumar   +3 more
core   +1 more source

Simultaneous Treatment of Two Severe Acute Intoxication and Acute Kidney Injury

open access: yesSeminars in Dialysis, Volume 38, Issue 2, Page 152-155, March/April 2025.
ABSTRACT Extracorporeal therapies could be required for treatment of life‐threatening severe acute intoxication. We present the case of an 82‐year‐old patient admitted to our Nephrology Unit because of metformin‐associated lactic acidosis (MALA) and acute kidney injury (AKI stage III AKIN criteria).
Fulvia Zappulo   +7 more
wiley   +1 more source

Contemporary Antithrombotic Drug Removal via Hemoadsorption in Cardiac Surgery

open access: yes
The incidence of severe bleeding in patients treated with dual antiplatelet therapy, including the new P2Y12 inhibitors or new direct oral anticoagulants, who are undergoing urgent cardiac surgery is very high.
Efthymios Deliargyris   +2 more
core   +1 more source

Supplementary Material for: Rationale of Hemoadsorption during Extracorporeal Membrane Oxygenation Support

open access: yes, 2019
Extracorporeal membrane oxygenation (ECMO) and extracorporeal life support are increasingly used for treating various forms of shock, lung failure, protected interventions and life support including resuscitation.
Napp L.C. (6706196)   +2 more
core   +1 more source

Fatal Liver Failure After Herpes‐Simplex‐Virus‐2‐Induced Acute Necrotizing Hepatitis: A Case Report

open access: yesCase Reports in Hepatology, Volume 2025, Issue 1, 2025.
Herpes simplex virus (HSV) infections are common in the European population, typically presenting with mucocutaneous and anogenital manifestations. However, disseminated infections and organ involvement are rare, usually occurring in immunocompromised individuals, particularly after hematopoietic stem cell or solid organ transplantation. HSV1/2‐induced
Thomas Rösner   +11 more
wiley   +1 more source

Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP): A single center, open‐label, three‐arm, randomized, controlled intervention pilot trial

open access: yesArtificial Organs, Volume 48, Issue 10, Page 1150-1161, October 2024.
Study design and primary endpoint (serum bilirubin after 72 h) of the randomized controlled pilot trail CYTOHEP. Abstract Background To investigate the efficacy of bilirubin reduction by hemoadsorption with CytoSorb® in patients with acute‐on‐chronic liver failure (ACLF) receiving continuous renal replacement therapy (CRRT).
Asieb Sekandarzad   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy